passages.id: split_8_test_738_passage
passages.type: progene_text
passages.text: b) The protein S100 as a tumor - marker of malignant High Risk melanomas has no clinically important sensitivity and specificity as could be proved by a comparison with the predictive value of FDG-PET. c ) Whether or not during therapy information concerning progression / remission of the disease can be received out of repetitive measurements of the S100 , has to be shown by the results of validated long term follow - up studies .